Biotech entity
Every one of those 2 sits in a single category, pharma. DelveInsight Business Research LLP is most often covered alongside Advanced Drug Delivery Technologies, which appears in 1 of these 2 stories. That works out to roughly 2 stories per week across a 7-day span.
Last mentioned: Mar 11, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 2 sits in a single category, pharma. DelveInsight Business Research LLP is most often covered alongside Advanced Drug Delivery Technologies, which appears in 1 of these 2 stories. That works out to roughly 2 stories per week across a 7-day span. They are less corroborated than the beat average, carrying 2 original sources each against 3.3 for the same window. The 6.5 average consequence score is above the beat benchmark of 6.1 in the same window. DelveInsight Business Research LLP appears in 2 tracked Biotech stories published from March 5, 2026 through March 11, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 93 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering DelveInsight Business Research LLP. Shared-story counts are live from our verified record — not editorial picks.
The global minimally invasive surgical devices market is projected to grow at a 7% CAGR through 2034, driven by technological advancements and a shift toward outpatient care. This growth reflects a broader healthcare transition prioritizing reduced recovery times and improved patient outcomes.
The global nanomedicine market is projected to exceed $550 billion by 2034, fueled by the rapid adoption of advanced drug delivery systems. This growth marks a significant shift toward precision therapeutics, particularly in oncology and neurology, as nanoparticles become the standard for targeted treatment.
DelveInsight Business Research LLP is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
